D.A. Davidson & CO. Acquires 39,279 Shares of Healthpeak Properties, Inc. $DOC

D.A. Davidson & CO. lifted its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 37.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 144,054 shares of the real estate investment trust’s stock after buying an additional 39,279 shares during the quarter. D.A. Davidson & CO.’s holdings in Healthpeak Properties were worth $2,759,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Mather Group LLC. bought a new stake in Healthpeak Properties during the third quarter worth about $25,000. City Holding Co. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $26,000. Sound Income Strategies LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $28,000. Rexford Capital Inc. purchased a new stake in shares of Healthpeak Properties in the 2nd quarter worth approximately $28,000. Finally, Elevation Point Wealth Partners LLC purchased a new position in Healthpeak Properties during the second quarter valued at $32,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Up 0.5%

Shares of DOC stock opened at $17.03 on Friday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.11. Healthpeak Properties, Inc. has a 12-month low of $15.71 and a 12-month high of $21.28. The stock has a market capitalization of $11.83 billion, a P/E ratio of -340.43, a P/E/G ratio of 4.29 and a beta of 1.12. The firm’s 50 day moving average is $17.06 and its 200 day moving average is $17.71.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. The business had revenue of $705.87 million during the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.1017 dividend. This represents a c) annualized dividend and a yield of 7.2%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio (DPR) is presently -2,440.00%.

Analyst Ratings Changes

DOC has been the topic of a number of recent research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a research note on Monday, December 29th. Robert W. Baird reduced their price objective on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. Wells Fargo & Company upped their target price on shares of Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. Evercore ISI cut their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, December 15th. Finally, Cantor Fitzgerald set a $17.00 price objective on shares of Healthpeak Properties in a report on Monday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $19.91.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.